SARC Semi-Annual Meeting Agenda
CTOS – November 10, 2016
Corinthia Hotel, Lisbon Portugal
8:30
8:35
Welcome
Opening Remarks
Chawla/Rosenfeld Developmental Therapeutics Symposium
Sarcoma Survivorship: Exploring the Issues
David Kirsch, MD, PhD
Introduction
Robert Maki, MD, PhD
Registries and Their Value in Quality of Life Assessment
Lonneke van de Poll-Franse, PhD
Bone Health in Sarcoma Survivors
Lara Davis, MD
The PanCare Network and Its Related Research Projects
Lars Hjorth, MD, PhD
The Challenge of Treating Secondary Sarcomas
Jennifer Wright, MD
10:15
Discussion/Q & A
10:30
Pediatric and Medical Oncology Forum
Break
Pediatric and Medical Oncology Collaboration:
The Obstacles, Challenges and Opportunities
11:00
Panel
Robert Maki, MD, PhD - Moderator
Lara Davis, MD
Uta Dirksen, MD PhD
Richard Gorlick, MD
Kirsten Sundby Hall, MD PhD
Katherine Janeway, MD
Robin Jones, MD
Shreyaskumar Patel, MD
Damon Reed, MD
SARC Career Development
Introduction
Richard Gorlick, MD
Lee Helman, MD
Elizabeth Lawlor, MD, PhD
2015 Career Development Awardees
Dissecting the Role of Injury in a Mouse
Model of Soft Tissue Sarcoma
Developing ptDNA and CTC in Ewing Sarcoma as a
Sensitive and Specific Biomarker
11:45
Masanori Hayashi, MD
Discussion / Q & A
Immunotherapy Trials in Sarcoma
Introduction
12:30
David Van Mater, MD, PhD
SARC Trials:
•
SARC028: Phase 2 trial of Pembrolizumab in
Advanced Sarcoma
•
SARC032: Phase 2 Randomized trial of
Pembrolizumab + RT in High Grade Extremity
Sarcomas
Immunotherapy Trials in Sarcoma
•
Summary of Global Landscape
Discussion: What’s next?
Adjourn
Scott Okuno, MD
Melissa Burgess, MD
David Kirsch, MD, PhD
Robert Maki, MD, PhD
THANK YOU
SARC gratefully acknowledges the following supporters:
Platinum Level
Gold Level
Silver Level
If you are interested in learning how to support SARC and more
about the funding levels, please feel free to contact SARC directly.
Email: [email protected] or 734-930-7600.